innovator to know

Houston Exponential exec moves over to The Ion

Joey Sanchez is now the senior director of ecosystems at The Ion. Photo via HX.com

From one Houston innovation ecosystem builder to the next — this Houston innovator has made a job change,

Joey Sanchez has been hired by The Ion as the senior director of ecosystems. Sanchez previously served as director of corporate engagement at Houston Exponential.

"This move signifies the continuity of a shared mission between both Houston Exponential and the Ion: growing the connectivity both within and outside of our entrepreneurial ecosystem," says Serafina Lalany, executive director of HX, in a news release from The Ion. "Houston's bright economic future in an ever-increasing tech-focused global economy will rely on collaboration, and we look forward to building towards this vision with partners such as the Ion."

In his new role, he will work with the Houston early-stage investing and startup community, including founders, early-stage startups, scaled startups, early-stage angel investors, venture capital investors, and corporate partners, to grow the Ion's presence in Houston.

"Houston and Texas are seeing unprecedented growth in tech and innovation. I am excited for the opportunity to continue building and supporting the Houston innovation ecosystem," says Sanchez the release. "An ecosystem needs harmony among all aspects involved, and I have always enjoyed connecting people. The overarching goal remains to build a vibrant ecosystem that supports a high frequency of connections between critical stakeholders to realize outsized success."

The Ion, a 266,000-square-foot building owned and operated by Rice Management Company, completed its construction earlier this year. The innovation hub has office space, shared workspace, prototyping and maker resources, event space, classrooms, and dining spaces. Sanchez will be tasked with delivering program activations that position the Ion as a destination for the community.

"Joey is a welcome addition to The Ion team and fills a critical role. The Ion continues to evolve into a nucleus of 'engineered serendipity' that can help businesses and people come across unexpected helpful connections," says Jan E. Odegard, executive director of The Ion. "He brings not just experience working with the types of companies we want to partner with but also deep knowledge of Houston's entrepreneurial community to our team."

Trending News

Building Houston

 
 

Houston-based medical device and biotech startup Steradian Technologies has been recognized by the Bill and Melinda Gates Foundation. Photo by Dwight C. Andrews/Greater Houston Convention and Visitors Bureau

A female-founded biotech startup has announced that it has received a grant from the Bill & Melinda Gates Foundation.

Steradian Technologies has developed a breath-based collection device that can be used with diagnostic testing systems. Called RUMI, the device is non-invasive and fully portable and, according to a news release, costs the price of a latte.

“We are extremely honored to receive this award and be recognized by the Bill & Melinda Gates Foundation, a leader in global health. This funding will propel our work in creating deep-tech diagnostics and products to close the equity gap in global public health," says Asma Mirza, CEO and co-founder of Steradian Technologies, in the release. “The RUMI will demonstrate that advanced technology can be delivered to all areas of the world, ensuring the Global South and economically exploited regions receive access to high-fidelity diagnostics instead of solutions that are ill-suited to the environment.”

RUMI uses novel photon-based detection to collect and diagnose infectious diseases in breath within 30-seconds, per the release, and will be the first human bio-aerosol specimen collector to convert breath into a fully sterile liquid sample and can be used for many applications in direct disease detection.

"As the healthcare industry continues to pursue less invasive diagnostics, we are very excited that the foundation has identified our approach to breath-based sample collection as a standout worthy of their support," says John Marino, chief of product development and co-founder. “We look forward to working with them to achieve our goals of better, faster, and safer diagnostics."

Founded in 2017, Steradian Technologies is funded and supported by XPRIZE, Johnson & Johnson’s Lung Cancer Initiative, JLABS TMCi, Capital Factory, Duke Institute of Global Health, and Johnson & Johnson’s Center for Device Innovation.

The amount granted by the Bill & Melinda Gates Foundation was not disclosed. The Seattle-based foundation is led by CEO Mark Suzman and co-chaired by Bill Gates and Melinda French Gatess.

Trending News